IN172210B - - Google Patents

Info

Publication number
IN172210B
IN172210B IN409/MAS/91A IN409MA1991A IN172210B IN 172210 B IN172210 B IN 172210B IN 409MA1991 A IN409MA1991 A IN 409MA1991A IN 172210 B IN172210 B IN 172210B
Authority
IN
India
Application number
IN409/MAS/91A
Other languages
English (en)
Inventor
Inder Singh Rattan Suresh
Original Assignee
Senetek Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27508530&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN172210(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from NZ238210A external-priority patent/NZ238210A/en
Application filed by Senetek Plc filed Critical Senetek Plc
Publication of IN172210B publication Critical patent/IN172210B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/606—Nucleosides; Nucleotides; Nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Birds (AREA)
  • Molecular Biology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Road Signs Or Road Markings (AREA)
  • Organic Insulating Materials (AREA)
  • Measuring Volume Flow (AREA)
  • Ink Jet (AREA)
  • Stroboscope Apparatuses (AREA)
  • Tea And Coffee (AREA)
  • Materials Applied To Surfaces To Minimize Adherence Of Mist Or Water (AREA)
  • Medicinal Preparation (AREA)
IN409/MAS/91A 1991-05-16 1991-05-29 IN172210B (2)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
PCT/US1991/003466 WO1992020341A1 (en) 1991-05-16 1991-05-16 Method and composition for ameliorating the adverse effects of aging
CA002108369A CA2108369C (en) 1991-05-16 1991-05-16 Method and composition for ameliorating the adverse effects of aging
NZ238210A NZ238210A (en) 1991-05-21 1991-05-21 Use of 6-(substituted amino) purine cytokinins for inhibiting effects of ageing on mammalian cells
IL9820491A IL98204A (en) 1991-05-16 1991-05-21 Cosmetic method and compositions for ameliorating the adverse effects of aging using 6-(substituted amino) purine cytokinins
CN91104472A CN1037235C (zh) 1991-05-16 1991-06-28 6-（取代氨基）嘌呤促细胞分裂素在制备抗衰老组合物中的用途

Publications (1)

Publication Number Publication Date
IN172210B true IN172210B (2) 1993-05-01

Family

ID=27508530

Family Applications (1)

Application Number Title Priority Date Filing Date
IN409/MAS/91A IN172210B (2) 1991-05-16 1991-05-29

Country Status (18)

Country Link
EP (1) EP0584068B2 (2)
JP (1) JP3103375B2 (2)
KR (1) KR100196660B1 (2)
CN (1) CN1037235C (2)
AT (1) ATE185272T1 (2)
AU (1) AU666836B2 (2)
BR (1) BR9107307A (2)
CA (1) CA2108369C (2)
DE (1) DE69131692T3 (2)
DK (1) DK0584068T4 (2)
ES (1) ES2140392T5 (2)
FI (1) FI111219B (2)
GR (1) GR3032325T3 (2)
IL (1) IL98204A (2)
IN (1) IN172210B (2)
NO (1) NO304814B1 (2)
NZ (1) NZ247836A (2)
WO (1) WO1992020341A1 (2)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001031549A (ja) * 1999-07-14 2001-02-06 Pola Chem Ind Inc 真皮コラーゲン線維束再構築剤及びそれを含有する化粧料
WO2002042440A2 (en) * 2000-11-25 2002-05-30 University Of Leeds Regulation of plant growth by modifying the expression of a putative trna-isope ntenyl transferase
DE10100122A1 (de) * 2001-01-03 2002-07-11 Henkel Kgaa Verfahren zur Bestimmung der Hautalterung in vitro
JP2002212052A (ja) * 2001-01-15 2002-07-31 Hajime Ito 外用組成物
KR20080070782A (ko) * 2001-04-13 2008-07-30 오츠카 세이야쿠 가부시키가이샤 당 흡수 촉진제
CZ294535B6 (cs) * 2001-08-02 2005-01-12 Ústav Experimentální Botaniky Avčr Heterocyklické sloučeniny na bázi N6-substituovaného adeninu, způsoby jejich přípravy, jejich použití pro přípravu léčiv, kosmetických přípravků a růstových regulátorů, farmaceutické přípravky, kosmetické přípravky a růstové regulátory tyto sloučeniny obsahující
JP4567307B2 (ja) * 2003-08-25 2010-10-20 株式会社ノエビア 皮膚外用剤
CN100493509C (zh) * 2007-06-04 2009-06-03 西北农林科技大学 化合物6-糠基氨基嘌呤用于制备抗睾丸衰老药物的应用
CN100493507C (zh) * 2007-06-04 2009-06-03 西北农林科技大学 化合物6-糠基氨基嘌呤制备抗雌性生殖器官损伤药物应用
CN100493510C (zh) * 2007-06-04 2009-06-03 西北农林科技大学 6-糠氨基嘌呤用于制备治疗心肌组织氧化损伤药物的应用
CN100493508C (zh) * 2007-06-04 2009-06-03 西北农林科技大学 化合物6-糠氨基嘌呤用于制备抗心肌缺血损伤药物的应用
CN100493506C (zh) * 2007-06-04 2009-06-03 西北农林科技大学 化合物6-糠基氨基嘌呤在制备抗脑组织氧化损伤药物应用
CZ302225B6 (cs) * 2007-07-04 2010-12-29 Univerzita Palackého v Olomouci Substituované 6-anilinopurinové deriváty jako inhibitory cytokinin oxidasy a prípravky obsahující tyto slouceniny

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1587633A (2) † 1968-07-04 1970-03-27
DD148889A3 (de) * 1974-08-19 1981-06-17 Forsch Die Gaerungsindustrie E Verfahren zur herstellung eiweissreicher hefen
JPS6019709A (ja) * 1983-07-14 1985-01-31 Tsunetaka Yokoyama 皮膚の老化防止及細胞分裂促進の化粧品の製造方法
DE3529497A1 (de) * 1985-08-17 1987-02-26 Boehringer Mannheim Gmbh N(pfeil hoch)6(pfeil hoch)-disubstituierte purinderivate, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel
US5021422A (en) * 1989-06-08 1991-06-04 Senetek Plc Method and composition for treating hyperproliferative skin diseases using 6-aminopurine cytokinins
JPH0619709A (ja) * 1992-04-29 1994-01-28 Sun Microsyst Inc パイプラインプロセッサを有するコンピュータシステム

Also Published As

Publication number Publication date
DE69131692T2 (de) 2000-03-16
ES2140392T5 (es) 2004-10-16
EP0584068A1 (en) 1994-03-02
DE69131692T3 (de) 2004-09-23
FI111219B (fi) 2003-06-30
EP0584068A4 (2) 1994-04-06
NO304814B1 (no) 1999-02-22
AU666836B2 (en) 1996-02-29
DK0584068T4 (da) 2004-06-14
EP0584068B2 (en) 2004-04-28
IL98204A (en) 1994-11-11
DK0584068T3 (da) 2000-04-10
BR9107307A (pt) 1994-06-14
ES2140392T3 (es) 2000-03-01
GR3032325T3 (en) 2000-04-27
FI935039L (fi) 1993-11-15
NO934115L (no) 1994-01-17
WO1992020341A1 (en) 1992-11-26
JPH10510240A (ja) 1998-10-06
DE69131692D1 (de) 1999-11-11
ATE185272T1 (de) 1999-10-15
FI935039A0 (fi) 1993-11-15
AU8188491A (en) 1992-12-30
CN1068033A (zh) 1993-01-20
CN1037235C (zh) 1998-02-04
NO934115D0 (no) 1993-11-15
JP3103375B2 (ja) 2000-10-30
KR100196660B1 (ko) 1999-06-15
CA2108369A1 (en) 1992-11-17
EP0584068B1 (en) 1999-10-06
NZ247836A (en) 1997-03-24
CA2108369C (en) 2003-01-28

Similar Documents

Publication Publication Date Title
DE4290261T1 (2)
DK0498143T3 (2)
DE4291719T1 (2)
DE4292255T1 (2)
DE4291827T1 (2)
DK0539725T3 (2)
DE4291721T1 (2)
DK0511526T3 (2)
DE4193594T1 (2)
ECSDI910049S (2)
DK132791D0 (2)
ECSM91533U (2)
ECSM91543U (2)
ECSM91556U (2)
ECSM91561U (2)
ECSDI910041S (2)
AU8138491A (2)
AU8260191A (2)
AU8773791A (2)
AU8979091A (2)
AU8983291A (2)
AU8997191A (2)
CN3008237S (2)
CN3009643S (2)
CN3009746S (2)